Does a mandatory non-medical switch from originator to biosimilar infliximab lead to increased use of outpatient healthcare resources? A register-based study in patients with inflammatory arthritis

OriginalsprogEngelsk
ArtikelnummerPP68
BogserieScandinavian Journal of Rheumatology, Supplement
Vol/bind47
Udgave nummerSuppl. 129
Sider (fra-til)58-9
Antal sider2
ISSN0301-3847
StatusUdgivet - 2018

Citationsformater